Timothy Low
Healthcare Investment Consultant @ Pavilion Capital
Timothy Low is a Healthcare Investment Consultant at Pavilion Capital International. He Attended National University of Singapore.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Timothy Low invests in
Stages Timothy Low invests in
Countries Timothy Low invests in
Investment Focus
Industry
- Medical 1 (25%)
- Biotechnology 1 (25%)
- Pharmaceutical 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $46.5M / Venture - Series Unknown / Jun 16, 2021 | |
|
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $46.5M / Venture - Series Unknown / Jun 16, 2021 | |
|
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $18M / Venture - Series Unknown / Feb 25, 2020 | |
|
KAHR medical
|
KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders. | $18M / Venture - Series Unknown / Feb 25, 2020 |
Co-Investors
About Pavilion Capital
Pavilion Capital Partners is a growth-oriented private equity investor. It provides capital and strategic support to companies in the United States and Asia. In particular, the focus is on industries experiencing high growth due to globalization, technology, or demographic trends. It actively works with company founders/management to assistin strategic initiatives, mergers and acquisitions, and eventual liquidity. The pavilion is partnered with family offices and private equity funds and is based in New York City.
Pavilion Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Timothy Low
Healthcare Investment Consultant
|
|||
Jean-Francois Perrault
Founder
|
|||
|
Tow Heng Tan
CEO
|
|||
2 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Timothy Low invest in?
Timothy Low invests primarily in Medical, Biotechnology and Pharmaceutical startups, most often at Venture - Series Unknown stage. Most of the 4 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Timothy Low last invest?
The most recent investment recorded for Timothy Low closed in Jun 2021. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
